Propionyl-L-carnitine Propionyl-L-carnitine is not approved by the US FDA for use as a drug to prevent or treat any condition
Research on skeletal muscle biopsies from DMD patients has revealed decreased NAD + levels, increased PARP activity 253 and dysfunction of mitochondrial metabolism 254,266
4,5 What if metformin alone isn't enough
One paper [26] reviewing diabetic neuropathy included two RCTs [10,28] and concluded that ALC could relief neuropathic pain, while another paper reviewing HIV-associated neuropathy included one RCT [11] and suggested no superiority of ALC to placebo
5 Pharmacological effects of GIP, GLP-1 and their mimetics The pharmacological benefits of GIP, GLP-1, and their synthetic mimetics arise from their pleiotropic effects, encompassing at least five key functions: bolstering insulin secretion and survival of pancreatic -cells and modulating glucagon release by the pancreatic -cells in response to glycemic levels, acting on the satiety center in brain, slowing gastric emptying, regulating lipid and glucose metabolism through effects on adipose tissue and liver, and reducing systemic blood pressure